
Dehydrogenase
Dehydrogenases are enzymes involved in the oxidation-reduction reactions of metabolic pathways, playing a central role in energy production and cellular respiration. These enzymes are crucial for processes such as the citric acid cycle, glycolysis, and fatty acid oxidation. Dehydrogenase inhibitors are important tools in the study of metabolic diseases, cancer, and oxidative stress. At CymitQuimica, we provide a comprehensive selection of dehydrogenase inhibitors to support your research in metabolism, cancer biology, and biochemistry.
Found 302 products of "Dehydrogenase"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
DSM421
CAS:DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shownFormula:C14H11F5N6Purity:99.67% - 99.82%Color and Shape:SolidMolecular weight:358.27Ref: TM-T27214
1mg110.00€5mg259.00€10mg353.00€25mg533.00€50mg718.00€100mg945.00€200mg1,251.00€1mL*10mM (DMSO)301.00€PBRM
CAS:PBRM (17β-HSD1-IN-2) is a selective covalent inhibitor of 17β-HSD1, used in breast cancer and endometriosis research.Formula:C28H34BrNO2Purity:99.56% - 99.59%Color and Shape:SolidMolecular weight:496.48G6PD activator AG1
CAS:G6PD activator AG1 is a G6PD agonist that promotes G6PD oligomerization to a catalytically competent form.Formula:C24H30N4S2Purity:98.38% - 99.51%Color and Shape:SolidMolecular weight:438.65CPS-11
CAS:CPS-11, a Thalidomide analogue, shows potent, broad antitumor activity, especially in multiple myeloma cells.Formula:C14H12N2O5Purity:99.8% - 99.98%Color and Shape:SolidMolecular weight:288.26PKUMDL-WQ-2101
CAS:PKUMDL-WQ-2101 is a selective allosteric inhibitor of phosphoglycerate dehydrogenase with anti-tumor activity.Formula:C14H11N3O6Purity:99.57%Color and Shape:SolidMolecular weight:317.25ALDH1A3-IN-2
CAS:ALDH1A3-IN-2 is a potent ALDH1A3 inhibitor with an IC50 of 0.30 μM.ALDH1A3-IN-2 has potential for cancer disease research.Formula:C13H17NOPurity:99.84%Color and Shape:SolidMolecular weight:203.28CM037
CAS:CM037 (A-37) is a selective ALDH1A1 (acetaldehyde dehydrogenase 1A1) inhibitor (IC50; 4.6 µM) with antitumor activity and may be used in studies to eliminateFormula:C21H25N3O3S2Purity:99.77%Color and Shape:SolidMolecular weight:431.57IGP-1
CAS:iGP-1 is a cell-permeable mitochondrial sn-Glycerol 3-phosphate dehydrogenase (mGPDH) inhibitor.Formula:C17H15N3O3Purity:99.12% - 99.15%Color and Shape:SolidMolecular weight:309.32Ref: TM-T25526
2mg34.00€5mg49.00€10mg71.00€25mg126.00€50mg192.00€100mg304.00€200mg444.00€1mL*10mM (DMSO)84.00€BMS-823778
CAS:BMS-823778 is a potent inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) for the study of type 2 diabetes.Formula:C18H18ClN3OPurity:99.39% - 99.75%Color and Shape:SolidMolecular weight:327.81Ref: TM-T71394
1mg164.00€2mg234.00€5mg389.00€10mg532.00€25mg820.00€50mg1,063.00€100mg1,350.00€200mg1,783.00€hDHODH-IN-7
CAS:hDHODH-IN-7 (DHODH-IN-9) is a nitrogen-containing analog and is a human dihydrorotatory dehydrogenase inhibitor.Formula:C21H23FN4OPurity:99.87%Color and Shape:SolidMolecular weight:366.43Ref: TM-T11031
1mg115.00€2mg172.00€5mg255.00€10mg375.00€25mg562.00€50mg792.00€100mg1,064.00€500mg2,147.00€1mL*10mM (DMSO)266.00€IDH2R140Q-IN-2
CAS:IDH2R140Q-IN-2 is an IDH2R140Q inhibitor indicated for the study of acute myeloid leukaemia (AML).Formula:C21H18F6N6OPurity:99.92%Color and Shape:SolidMolecular weight:484.4Qc1
CAS:Qc1 is an inhibitor of threonine dehydrogenase (TDH) inhibitor and can be used in studies about metabolic diseases.Formula:C23H16F3N3O2SPurity:99.75%Color and Shape:SolidMolecular weight:455.45HSD-016
CAS:HSD-016: Oral 11β-HSD1 inhibitor, active in humans, mice, rats (IC50: 11, 1, 8 nM), potential for type 2 diabetes research.Formula:C21H21F7N2O3SPurity:99.40% - >99.99%Color and Shape:SolidMolecular weight:514.46Ref: TM-T63569
1mg84.00€5mg280.00€10mg439.00€25mg888.00€50mg1,485.00€100mg2,358.00€1mL*10mM (DMSO)310.00€GSK321
CAS:GSK321 is an IDH1 inhibitor that prevents cytoplasmic glutamine reductive carboxylation.GSK321 is used in the study of leukemia.Formula:C28H28FN5O3Purity:99.73%Color and Shape:SolidMolecular weight:501.55DHODH-IN-22
CAS:DHODH-IN-22: potent, selective DHODH inhibitor, orally active, IC50: 0.3 nM, for AML research.Formula:C21H21ClF4N6O5Color and Shape:SolidMolecular weight:548.88Anticancer agent 122
CAS:Anticancer agent 122, a potent inhibitor of human lactate dehydrogenase A (h LDHA), exhibits significant anticancer activities, rendering it suitable for use inFormula:C18H15ClN2O2SColor and Shape:SolidMolecular weight:358.84AKR1C3-IN-6
CAS:AKR1C3-IN-6: Strong AKR1C3 inhibitor (IC50: 0.31 μM); weak on AKR1C2 (IC50: 73.23 μM); shows antitumor effects.Formula:C18H15F3N4O3Color and Shape:SolidMolecular weight:392.3311α-Hydroxyprogesterone
CAS:11alpha-Hydroxyprogesterone, an inactive analogue of 11beta-Hydroxyprogesterone, serves as an experimental control. Meanwhile, 11beta-Hydroxyprogesterone functions as a potent inhibitor of 11β-Hydroxysteroid dehydrogenase and activates the human mineralocorticoid receptor in COS-7 cells, with an effective dose (ED)50 of 10 nM.Formula:C21H30O3Color and Shape:SolidMolecular weight:330.468Tetrahydro-11-dehydrocorticosterone
CAS:Tetrahydro-11-dehydrocorticosterone is an inhibitor of 11β-hydroxysteroid dehydrogenase [1].Formula:C21H32O4Color and Shape:SolidMolecular weight:348.48HSD17B13-IN-3
CAS:HSD17B13-IN-3 (compound 2) is a potent inhibitor of hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13), lacking cellular experimental activity [1].Formula:C22H21NO6S2Color and Shape:SolidMolecular weight:459.54
